Upload Avatar (500 x 500)
Wei Wang
weiwang@hmfl.ac.cn
Chinese, English, German
Anhui
University of Science and Technology of China
Mayo Clinic College of Medicine
  • 2002/09–2006/06 Bachelor's in Biotechnology: Shandong University
  • 2007/09 - 2010/06 Master's in Biochemistry and Molecular Biology: Northwest A&F University, Supervisor: Professor Guo Zekun
  • 2010/09 – 2013/09 PhD in Biology: University of Kiel, Supervisor: Prof. Thomas C.G. Bosch
  • 2013/09 – 2015/10 - University of Kiel - Postdoctoral Researcher
  • 2015/11 – 2019/03 - Institute of Solid State Physics, Chinese Academy of Sciences - Assistant Researcher
  • 2019/04 – 2019/12 - The First Affiliated Hospital of USTC - Assistant Researcher
  • 2019/12 – Present - The First Affiliated Hospital of USTC - Associate Researcher
Tumor stem cells and tumor microenvironment
Tumor biomarkers
Cancer screening, diagnosis, treatment, and efficacy monitoring technologies
  • A nodal EBV-positive T cell lymphoma with a T follicular helper cell phenotype., Zhaoxuan Zhang*, Wei Wang*, Yuan Li, Zhouyi Xu, Haibo Wu, Zhe Wang#., 2023
  • BCOR-CCNB3 sarcoma with concurrent RNF213-SLC26A11 gene fusion: a rare sarcoma with altered histopathological features after chemotherapy., Wen Huang*, Wei Wang*, Liang-Liang Huang, Heng Li, Wen-Chao Zhou#, Hai-Bo Wu#., 2022
  • Aberrant expression of thyroid transcription factor-1 in meningeal solitary fibrous tumor / hemangiopericytoma., Haibo Wu*, Jun Du*, Heng Li, Yujie Li, Wanqiu Zhang, Wenchao Zhou, Wei Wang#., 2021
  • The prognostic value of retraction clefts in Chinese invasive breast cancer patients., Liangliang Huang*, Yujie Li*, Jun Du, Heng Li, Mengmeng Lu, Yuting Wang, Wenchao Zhou, Wei Wang#, Haibo Wu#., 2021
  • CircularLRRC7 is a potential tumor suppressor associated with miR-1281 and PDXP expression in glioblastoma., Xue Kong*, Ruiting Xu*, Wei Wang*, Minghui Zeng, Yuan Li, Mengyu Lin, Wenchao Zhou#, Xianming Fu#, Haibo Wu#., 2021
  • Vasculogenic mimicry formation predicts tumor progression in oligodendroglioma., Jing Xie*, Xue Kong*, Wei Wang*, Yuan Li, Mengyu Lin, Heng Li, Jingjing Chen, Wenchao Zhou#, Jie He#, Haibo Wu#., 2021
  • The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China., Haibo Wu*, Wei Wang*, Jun Du*, Hong Li, Liangliang Huang, Huogang Wang, Jing Xie, Hang Xiang, Heng Li, Ning Zhang, Wenchu Lin#., 2019
  • Germline mutation and aberrant transcript of WWOX in a syndrome with multiple primary tumors., Xu A*, Wang W*, Nie J, Liu VWY, Hong B#, Lin W#., 2019
Tumor Stem Cells Microenvironment Biomarkers Cancer Screening Diagnosis Treatment Efficacy Monitoring

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.